These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 15058791

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Low-dose (1.25 mg/kg) cyclosporin A: treatment of psoriasis and investigation of the influence on lipid profile.
    Meffert H, Bräutigam M, Färber L, Weidinger G.
    Acta Derm Venereol; 1997 Mar; 77(2):137-41. PubMed ID: 9111826
    [Abstract] [Full Text] [Related]

  • 26. A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions.
    Bhutani T, Patel T, Koo B, Nguyen T, Hong J, Koo J.
    J Am Acad Dermatol; 2013 Aug; 69(2):e79-88. PubMed ID: 23207011
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis.
    Maza A, Montaudié H, Sbidian E, Gallini A, Aractingi S, Aubin F, Bachelez H, Cribier B, Joly P, Jullien D, Le Maître M, Misery L, Richard MA, Ortonne JP, Paul C.
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():19-27. PubMed ID: 21388455
    [Abstract] [Full Text] [Related]

  • 33. The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasis.
    Hakkaart-van Roijen L, Verboom P, Redekop WK, Touw KR, Rutten FF.
    Pharmacoeconomics; 2001 May; 19(5 Pt 2):599-608. PubMed ID: 11465304
    [Abstract] [Full Text] [Related]

  • 34. The Impact of Changes in Psoriasis Area and Severity Index by Body Region on Quality of Life in Patients with Psoriasis.
    Sojević Timotijević Z, Majcan P, Trajković G, Relić M, Novaković T, Mirković M, Djurić S, Nikolić S, Lazić B, Janković S.
    Acta Dermatovenerol Croat; 2017 Oct; 25(3):215-222. PubMed ID: 29252174
    [Abstract] [Full Text] [Related]

  • 35. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
    Heydendael VM, Spuls PI, Opmeer BC, de Borgie CA, Reitsma JB, Goldschmidt WF, Bossuyt PM, Bos JD, de Rie MA.
    N Engl J Med; 2003 Aug 14; 349(7):658-65. PubMed ID: 12917302
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.
    Menter A, Gordon K, Carey W, Hamilton T, Glazer S, Caro I, Li N, Gulliver W.
    Arch Dermatol; 2005 Jan 14; 141(1):31-8. PubMed ID: 15655139
    [Abstract] [Full Text] [Related]

  • 37. Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis.
    Bergstrom KG, Arambula K, Kimball AB.
    Cutis; 2003 Nov 14; 72(5):407-11. PubMed ID: 14655784
    [Abstract] [Full Text] [Related]

  • 38. Long-term continuous versus intermittent cyclosporin: therapy for psoriasis.
    Ohtsuki M, Nakagawa H, Sugai J, Ozawa A, Ohkido M, Nakayama J, Hanada J, Morimoto Y, Jimbow K, Horikoshi T, Kitahara H, Tamaki K, Urabe K, Hori Y.
    J Dermatol; 2003 Apr 14; 30(4):290-8. PubMed ID: 12707465
    [Abstract] [Full Text] [Related]

  • 39. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
    Reich K, Nestle FO, Papp K, Ortonne JP, Wu Y, Bala M, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CE.
    Br J Dermatol; 2006 Jun 14; 154(6):1161-8. PubMed ID: 16704649
    [Abstract] [Full Text] [Related]

  • 40. Short- and long-term considerations concerning the management of plaque psoriasis with low-dose cyclosporin. Studio Italiano Multicentrico nella Psoriasi (SIMPSO).
    Dermatology; 1993 Jun 14; 187 Suppl 1():19-29. PubMed ID: 8369576
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.